Thomas W. Dubensky, Chief Scientific Officer at ADURO BIOTECH, INC. (ADRO), sold 5,699 shares at $9.91 ($57K) on 2017-05-11, disclosed to the SEC on 2017-05-15.
Scheduled sale ($57k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.91 | 1,400 | $14K | 24.5% |
| 2 | $9.92 | 4,299 | $43K | 75.5% |
| Total | $9.92 avg | 5,699 | $57K | 100% |
| Filing → |
| ADRO | SELL | 2017-07-06 | $567K | — | Filing → |
| ADRO | SELL | 2017-06-05 | $1.4M | — | Filing → |
| ADRO | SELL | 2017-03-10 | $274K | — | Filing → |